These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17710790)

  • 1. Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease.
    Tincani A; Scarsi M; Franceschini F; Cattaneo R
    Isr Med Assoc J; 2007 Jul; 9(7):553-4. PubMed ID: 17710790
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of antiphospholipid syndrome in pregnancy with low doses of intravenous immunoglobulin.
    Stojanovich L; Mikovic Z; Mandic V; Popovich-Kuzmanovich D
    Isr Med Assoc J; 2007 Jul; 9(7):555-6. PubMed ID: 17710791
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al.
    Kaaja R; Julkunen H
    Arthritis Rheum; 2003 Jan; 48(1):280-1; author reply 281-2. PubMed ID: 12528144
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study.
    Heilmann L; Schorch M; Hahn T; Adasz G; Schilberz K; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2008 Nov; 34(8):794-802. PubMed ID: 19214917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure.
    Wisløff F; Crowther M
    Thromb Res; 2004; 114(2):75-81. PubMed ID: 15306148
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of recurrent congenital heart block in a SSA/SSB positive mother using high dose maternal IVIG from 16-week gestation.
    Sterling RA; Carlin A
    Prenat Diagn; 2015 Nov; 35(11):1148-50. PubMed ID: 26179183
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature.
    Ruffatti A; Marson P; Pengo V; Favaro M; Tonello M; Bortolati M; Minucci D; De Silvestro G
    Autoimmun Rev; 2007 Jan; 6(3):196-202. PubMed ID: 17289557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
    Makino S; Yonemoto H; Itoh S; Takeda S
    Acta Obstet Gynecol Scand; 2007; 86(9):1145-6. PubMed ID: 17712660
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of the combined treatment with immunoglobulins and plasmapheresis in a pregnant woman with Rh alloimmunization and antiphospholipid antibodies].
    Canales MA; Sevilla J; Hernández D; Hernández Navarro F
    Med Clin (Barc); 1999 Oct; 113(11):438-9. PubMed ID: 10562958
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol.
    Stone S; Hunt BJ; Khamashta MA; Bewley SJ; Nelson-Piercy C
    J Thromb Haemost; 2005 Feb; 3(2):243-5. PubMed ID: 15670028
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current obstetrical management of antiphospholipid antibody syndrome: review of the literature apropos of 20 cases].
    Denis E; Dufour P; Vinatier D; Valat AS; Subtil D; Puech F; Hatron PY
    Contracept Fertil Sex; 1998 Sep; 26(9):613-20. PubMed ID: 9823689
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy.
    Mosca M; Strigini F; Carmignani A; D'ascanio A; Genazzani AR; Bombardieri S
    Arthritis Rheum; 2005 Feb; 53(1):119-21. PubMed ID: 15696574
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.
    Ruffatti A; Tonello M; Cavazzana A; Bagatella P; Pengo V
    Thromb Res; 2009; 123(3):482-7. PubMed ID: 18462781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block.
    Ruffatti A; Favaro M; Brucato A; Ramoni V; Facchinetti M; Tonello M; Del Ross T; Calligaro A; Hoxha A; Grava C; De Silvestro G
    Transfus Apher Sci; 2015 Dec; 53(3):269-78. PubMed ID: 26626966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin and antiphospholipid syndrome: comment on the article by Erkan et al.
    Jean R; Bastard E; Cretel E; Lefèvre P; Durand JM
    Arthritis Rheum; 2004 Aug; 50(8):2711; author reply 2711-3. PubMed ID: 15334491
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous immunoglobulin in antiphospholipid syndrome and maternal floor infarction when standard treatment fails: a case report.
    Chang P; Millar D; Tsang P; Lim K; Houlihan E; Stephenson M
    Am J Perinatol; 2006 Feb; 23(2):125-9. PubMed ID: 16506120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital heart block and mother's immunology.
    Brucato A
    Circulation; 1997 Oct; 96(8):2735. PubMed ID: 9355920
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: comment on the letter by Kaaja and Julkunen.
    Tran HB; Cavill D; Buyon JP; Gordon TP
    Arthritis Rheum; 2004 Jan; 50(1):337-8; author reply 338. PubMed ID: 14730639
    [No Abstract]   [Full Text] [Related]  

  • 20. Landry Guillian-Barre Strohl syndrome in pregnancy: use of high-dose intravenous immunoglobulin.
    Seoud M; Naboulsi M; Khalil A; Sarouphim P; Azar G; Khalifeh R
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):912-3. PubMed ID: 10577623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.